Back to search
Recurrent C. Difficile (rCDI)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent C. Difficile (rCDI) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent C. Difficile (rCDI) trials you may qualify forThe gut microbiota plays a key role in immunity and metabolism and contributes to diseases such as recurrent C. difficile infection (rCDI), ulcerative colitis (…
The goal of this clinical trial is to learn if oral lyophilized fecal microbiota therapy (ORAL-LYO-FMT) helps treat diarrhea-predominant irritable bowel syndrom…
The purpose of this study is to determine whether a single strain capsulated probiotic, when used after standard C. difficile antibiotic therapy, is effective i…
Subjects with recurrent C. difficile infection will receive an oral dose of CP101 capsules one time in Treatment Group I or matching placebo one time in Treatme…
This is an open-label study evaluating the safety and efficacy of CP101 treatment in 1) Subjects in CDI-001 who had a CDI recurrence within 8 weeks of receiving…